News


News

Established Institute for Drug Development

The medical faculty of the University of Leipzig has one more institute: the Institute for Drug Development was founded at the beginning of the new year. It is located in the Medical Research Center, Liebigstraße 19, and is intended to bring basic research and clinical application in the field of new active substances in medicine closer together.
more

With the molecular "vacuum cleaner" against anemia in senile leukemia

In people with myelodysplastic syndrome (MDS), a mostly benign form of senile leukemia, the body produces too few functional blood cells. They suffer from anemia, also known as "anaemia", which can be a precursor to acute leukemia. So far, there have been hardly any treatment options for patients other than regular blood transfusions. The drug luspatercept, which acts like a "vacuum cleaner" in a figurative sense, was able to significantly improve the blood values ​​of those affected in a study by the German MDS study group. The worldwide follow-up study led by Prof. Dr. Uwe Platzbecker has confirmed the effectiveness of the preparation. It was recently published in the prestigious New England Journal of Medicine
more

CO.DON receives manufacturing license for in-house and commissioned production at the Leipzig location

After the first acceptance inspection by the national authority PEI (Paul Ehrlich Institute) and the Saxony State Directorate, CO.DON AG received the manufacturing license for its newly built production facility at the Leipzig location.
more

University hospitals in Leipzig and Jena are developing a joint oncological center of excellence

Leipzig. The University Hospital Leipzig (UKL) and the University Hospital Jena (UKJ) plan to jointly develop a Comprehensive Cancer Center (CCC) funded by the German Cancer Aid. The partners have now signed a letter of intent. The University Cancer Center Leipzig (UCCL) at the UKL and the University Tumor Center (UTC) Jena are working together on the project.
more

Zellkraftwerk/Canopy Biosciences: Immune Profiling Platform continues to grow

The German-American company Zellkraftwerk / Canopy Biosciences merged with another partner in the USA at the end of 2019 and announced the acquisition of Core Diagnostics. The company is one of the leading CLIA-certified providers of biomarker analysis services for biopharmaceutical research.
more